Valeant Pharmaceuticals International Company Profile

Aggregated data from the web about Valeant Pharmaceuticals International

Company Name	Valeant Pharmaceuticals International
Website	https://www.bauschhealth.com
Snippet	The decision to change our name was considered carefully over a long period of time. We looked at a number of available options and determined that Bausch Health most accurately represents the full scope of our portfolio, which includes not only pharmaceuticals, but also medical devices and over-the-counter consumer health products. Read more »
ISIN	CA91911K1021
Type	Public
Founded	1959
Founder	Milan Panić
Revenue	US$8.380 billion (2018)[1]
Website	www.bauschhealth.com
Industry	Pharmaceuticals
Traded as	TSX: BHCS&P/TSX 60 component
Key people	Joseph C. Papa(Chairman & CEO)Paul S. Herendeen(Executive VP & CFO)Sam Eldessouky(Senior VP & Controller)
Net income	US$-4.148 billion (2018)[1]
Headquarters	Laval, Quebec, CanadaBridgewater, New Jersey, US
Subsidiaries	Bausch & LombSalix PharmaceuticalsMedicis PharmaceuticalSolta MedicalOraPharma
Total assets	US$32.492 billion (2018)[1]
Total equity	US$2.733 billion (2018)[1]
Operating income	US$-2.384 billion (2018)[1]
Number of employees	~21,100 (December 2018)[1]

Valeant Pharmaceuticals International is part of the Canada company list

Valeant Pharmaceuticals International is part of the Pharmaceuticals company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.